ST

Senthilmurugan Thyagarajan

Active Director Additional Director DIN 07009811
DIN 07009811 First appointment Nov 2014 Primary industry Pharma
Unlock full profile Investments Β· shareholding Β· contact details
Current companies 4 active board seats
Past companies 4 historical roles
Total affiliations 8 Since Nov 2014
Shareholding value β€’β€’β€’β€’ Premium profile

About Senthilmurugan Thyagarajan

Data last updated:

Senthilmurugan Thyagarajan is an Additional Director at Bioradius Therapeutic Research Private Limited (since 2021), Designated Partner at Medcare Enterprises Llp (since 2016) and Designated Partner at Bioclin Research Llp (since 2015), and holds 1 more current directorship. The companies operate in Pharma, Business Services and Healthcare. The largest current company by reported revenue is Bioradius Therapeutic Research Private Limited at ₹6.11 Cr (FY 2024). Earlier, Senthilmurugan Thyagarajan was a Designated Partner at Novo Cellular Medicine Institute Llp (2015–2020) and Director at Orthonovus Healthcare India Private Limited (from 2015) and 2 more.

DIN 07009811
Primary Designation Additional Director
Industry Pharma
First Appointment 25 Nov 2014
Oldest Company Age 11 yrs
Largest company Bioradius Therapeutic Research Private Limited Β· ₹6.11 Cr (FY 2024)

Current companies

CompanyDesignationAppointmentFoundedRevenueStatus
Additional Director18 Mar 20212018₹6.11 Cr (FY 2024)Active
Designated Partner13 May 20162016Active
Designated Partner28 Apr 20152015Active
Director25 Nov 20142014Active

Previous companies

CompanyDesignationAppointmentFoundedRevenueStatus
Designated Partner04 Dec 20152015Strike Off
Director22 Jul 20152015₹11.4 Lakh (FY 2016)Strike Off
Designated Partner23 Jan 20152015Strike Off
Designated Partner23 Jan 20152015Strike Off

Explore Director's current and past company associations Uncover their professional journey today!

Directorship timeline

Open interactive timeline →
Green India Nutraceutical Private Limited
Orthonovus Healthcare India Private Limited
Bioradius Therapeutic Research Private Limited
Medcare Enterprises Llp
Premium access

Shareholding and investment profile for Senthilmurugan Thyagarajan

Company-level share counts, filed values, and quarterly changes require authenticated premium access.

  • Company-level holdings
  • Filed share counts
  • Reported values
  • Quarterly changes
Unlock shareholding

Verified entity values are shown only after access is granted.

Frequently Asked Questions about Senthilmurugan Thyagarajan

Senthilmurugan Thyagarajan currently holds 4 directorships: Bioradius Therapeutic Research Private Limited (Additional Director, since 18 Mar 2021, revenue β‚Ή6.11 Cr (FY 2024)); Medcare Enterprises Llp (Designated Partner, since 13 May 2016); Bioclin Research Llp (Designated Partner, since 28 Apr 2015); Green India Nutraceutical Private Limited (Director, since 25 Nov 2014).

Senthilmurugan Thyagarajan was first appointed on 25 Nov 2014 as Director at Green India Nutraceutical Private Limited. The most recent appointment on record is 18 Mar 2021 at Bioradius Therapeutic Research Private Limited.

Senthilmurugan Thyagarajan held 4 earlier board appointments: Novo Cellular Medicine Institute Llp (Designated Partner, 04 Dec 2015 to 25 Dec 2020); Orthonovus Healthcare India Private Limited (Director, from 22 Jul 2015); Omnistem Cellular Therapeutics Llp (Designated Partner, from 23 Jan 2015); Cordbless Cord Bloodbanking Services Llp (Designated Partner, from 23 Jan 2015).

The current boards of Senthilmurugan Thyagarajan's companies include Krishnaveni Gadiraju (Bioradius Therapeutic Research Private Limited), Dinesh Purushottam Shende (Medcare Enterprises Llp), Prakash Damodar Loharkar (Bioclin Research Llp), Pramod Shivajirao Dhembare (Bioclin Research Llp), Sanjay Laxman Veer (Green India Nutraceutical Private Limited).

Explore millions of companies β€” effortlessly

Access structured, verified intelligence on 7M+ companies across industries, sectors, and global markets. From early-stage startups to large enterprises, discover ownership, leadership, funding, financials, acquisitions, and market signals β€” all in one powerful platform.

Free account with essential features Instant access to company reports Enterprise solutions available